ALYI - BUY Recommendation Following $10 Billion Industrial Hemp Sector Market Penetration Announcement

New York, NY -- January 30, 2018 -- InvestorsHub NewsWire -- Alternet Systems, Inc. (USOTC: ALYI) is rated a BUY today by AmericanBulls.com. The ALYI PPS is moving toward a $0.01 breakthrough toward a recent analyst recommended $0.09 after the company yesterday released a management update highlighting the company’s hemp energy initiative following the 2018 Farm Act legalizing the farming of hemp in the United States. Grand View Research anticipates the industrial hemp market to grow to $10.6 billion by 2025. Forbes recently featured hemp energy storage and specifically the consultant engaged by ALYI to accelerate ALYI’s program. ALYI’s release yesterday also included an update on the company’s latest developments with $1.5 million in Revolt Electric Motorcycle orders.

In October last year, Alternet initiated a project to develop hemp-based technologies for energy storage. The company engaged Clarkson University Professor David Mitlin to lead the initiative. Professor Mitlin is a leading expert in electrochemistry and a pioneer in the use of hemp as a clean, green, renewable energy in the form of a supercapacitor. Mitlin has successfully used hemp bast – the fiber left over from processing hemp – to construct carbon nanosheets that compete with, and in some respects, outperform the supercapacitor performance derived from more typical graphene nanosheets.

AmericanBulls.com on ALYI

“Our system’s recommendation today is to BUY. The BULLISH ENGULFING pattern finally received a confirmation because the prices crossed above the confirmation level which was at 0.0076, and our valid average buying price stands now at 0.0087.

Let’s jump on our white horses and go for a bullish ride. The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. The market is telling you about a new profit. Do not miss this bullish opportunity.”

Other companies making market news and worth a watch include Helios and Matheson Analytics Inc. (HMNY), Endonovo Therapeutics, Inc. (ENDV) and Hemp, Inc. (HEMP).

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

Source: www.nextbigticker.com